Qingdao NovelBeam Technology Co., Ltd. Class A

Qingdao NovelBeam Technology Co., Ltd. Class A

SSSE:688677
59.00
CNY
-3.84
(-6.11%)
1.13EPS
86.38P/E
12.12BMarket Cap
Oct 24Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.09
1.54
1.63
3.01
1.9
2.08
2.71
3.02
2.65
3.92
3.88
3.66
5.08
5.03
Basic EPS, GAAP
-0.02
0.15
0.34
0.71
0.54
0.56
0.77
1.06
1.01
1.5
1.2
1.12
1.44
1.17
Free Cash Flow per Basic Share
-0.4
-0.15
0.09
0.58
0.61
0.15
0.46
0.51
0.03
0.02
0.84
0.3
1.12
- -
Dividend per Share
0.09
0.13
0.11
0.08
0.02
0.35
0.36
0.02
0.31
0.3
0.57
0.55
0.62
1.23
Book Value per Share
1.33
1.46
1.99
2.99
4.08
4.57
2.41
3.46
8.96
10.01
10.63
10.81
11.24
11.17
Tangible Book Value per Share
0.98
1.14
1.67
2.67
3.77
3.89
2.05
3.1
8.7
9.76
10.38
10.53
10.97
10.9
Basic Weighted Avg Shares
48
44
45
46
95
97
93
91
117
122
121
121
119
118
Sales/Revenue/Turnover
52
68
74
139
181
201
253
275
310
477
471
443
603
594
Operating Margin (%)
4.94
16.72
21.38
26.79
35.77
31.94
33.43
43.61
40.5
40.27
34.62
34.98
34.52
29.84
Depreciation Expense
4
5
6
6
6
7
8
9
10
15
24
29
36
- -
Net Income, GAAP
-1
7
16
33
51
55
72
96
118
183
146
135
171
138
Effective Tax Rate (%)
- -
14.16
4.04
8.02
11.74
12.06
11.86
13.46
12.07
11.57
11.28
12.28
13.04
11.61
Profit Margin (%)
-1.79
9.74
21.08
23.49
28.22
27.18
28.45
35.01
38.02
38.29
30.96
30.56
28.33
23.29
Working Capital
16
-4
11
45
84
97
59
116
793
751
820
713
813
737
LT Debt
40
35
25
15
- -
- -
10
19
19
2
4
1
59
47
Total Equity
63
70
95
142
194
229
225
320
1,095
1,222
1,293
1,305
1,345
1,334
Return on Invested Capital (%)
- -
3.52
9.39
18.65
25.84
25.18
28.44
29.98
15.77
15.32
11.13
10.12
11.6
8.9
Return on Capital (%)
- -
4.93
10.54
18.89
27.58
25.04
28.61
31.02
15.96
15.58
11.78
10.42
12.6
9.99
Return on Common Equity (%)
- -
9.97
18.9
27.66
30.39
26.1
32.39
35.98
16.74
15.81
11.6
10.43
12.88
10.32

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
85
73
132
LT Borrowings
59
37
47
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
120
120
120
Market Capitalization
5,174
6,556
12,123

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,032
1,013
993
Cash, Cash Equivalents & STI
631
616
581
Accounts Receivable, Net
107
106
97
Inventories
260
258
273
Total Current Liabilities
219
196
256
Payables & Accruals
- -
- -
- -
ST Debt
85
73
132
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
40.88%
52.77%
3.01%
Free Cash Flow
457.36%
751.68%
269.17%
Net Income, GAAP
31.55%
15.22%
26.15%
Sales/Revenue/Turnover
26%
19.07%
36.08%
Total Cash Common Dividend
333.41%
379.96%
11%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
118
103
98
124
443
2025
147
119
- -
155
603
2026
174
146
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.32
0.27
0.22
0.32
1.12
2025
0.39
0.23
- -
0.29
1.44
2026
0.4
0.25
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.01
- -
0.55
2025
- -
0.6
- -
0.01
0.62
2026
- -
0.61
- -
- -
- -

Company Description

CEO
Yao Zheng
Full Time Employees
1,070
Sector
Electronic technology
Industry
Electronic components
Address
No.100 Keyuanweisi Road Qingdao SD China 266100
IPO Date
Feb 26, 2021
Business
Qingdao NovelBeam Technology Co., Ltd. engages in the research, development, production and sales of optical instruments and components for medical, life science, laser, biometrics and micro-display projection applications. Founded in 2003 and headquartered in Qingdao, Shandong Province, China, the company offers endoscope camera couplers, camera lenses, surgical visualization devices including endoscopes, light sources, camera systems, surgical imaging systems and endoscopic systems; precision optical components such as filters, laser optics, lightguides, beamsplitters, fluorescent filters, IPL filters and high-energy laser scan lenses; light source modules for microscopes and PCR analysis; dental endoscopes; and biometric solutions encompassing fingerprint, palm print and palm vein scanners along with data management and identity management platforms for healthcare, finance, military, public security, education and transportation sectors. NovelBeam operates R&D centers and manufacturing bases in Qingdao, Zibo in China, the United States and Thailand, serving over 500 customers across more than 15 countries and regions through its divisions including Optical Division, Medical Division, Zibo Optics, OMEC NV for endoscope assembly and repair, NovelBeam CA for R&D and customer service, and OMEC Thai for optical modules and endoscopes. Recent developments include participation in major industry exhibitions such as the 24th CIOE in September 2023, LASER World of Photonics China 2023 and LASER World of Photonics 2023, underscoring ongoing expansion in precision optics for micro optics, in vitro diagnostics, stomatology and industrial laser applications.